The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.
Hermán-Sánchez N, G-García ME, Jiménez-Vacas JM, Yubero-Serrano EM, López-Sánchez LM, Romero-Martín S, Raya-Povedano JL, Álvarez-Benito M, Castaño JP, Luque RM, Gahete MD.
Hermán-Sánchez N, et al. Among authors: romero martin s.
Cell Mol Life Sci. 2024 Dec 27;82(1):18. doi: 10.1007/s00018-024-05515-6.
Cell Mol Life Sci. 2024.
PMID: 39725737
Free PMC article.